GoodRx Holdings, Inc. (GDRX) › Cash & EquivalentsGoodRx Holdings, Inc. (GDRX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $34.60M2019: $26.05M2020: $968.69M2021: $941.11M2022: $757.16M2023: $672.30M2024: $448.35M2025: $261.82M$261.82M2018Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$261.82M-41.6%2024$448.35M-33.3%2023$672.30M-11.2%2022$757.16M-19.5%2021$941.11M-2.8%2020$968.69M+3618.6%2019$26.05M-24.7%2018$34.60M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share